Occupational Activity – Page 3

Galapagos Walks Back Split Plans, Raising Questions Over Cell Therapy Assets

2 months ago talkbio0Tagged Appointments, Automobiles, biotech industry, Cell Therapy, CEO, Company Split, Galapagos, spinoff, T business

Galapagos; company split; cell therapy; spinoff; CEO appointment; biotech industry; CAR T business

UnitedHealth Group CEO Andrew Witty Steps Down; Stephen Hemsley Returns as CEO

2 months ago talkbio0Tagged Andrew Witty, CEO, financial guidance suspension, Leadership Change, personal reasons, Stephen Hemsley, stock drop, Transition Mutation, UnitedHealth Group

UnitedHealth Group; Andrew Witty; Stephen Hemsley; CEO transition; leadership change; personal reasons; financial guidance suspension; stock drop

Fortrea CEO Steps Down Amid Continued Stock Decline Post-Labcorp Spinout

2 months ago talkbio0Tagged CEO, Clinical Trials, CRO, departure - ActRelationshipType, Fortrea, Labcorp, Leadership Change, public company, Stock Decline

Fortrea; Labcorp; CEO departure; stock decline; CRO spinout; leadership change; clinical trials; public company

Where AI Adds Real Value in Clinical Development: 2025 Insights

2 months ago talkbio0Tagged Aortic Valve Insufficiency, Clinical Development, Clinical Trials, Data Analysis, Drug Discovery, protocol design, Recruitment, Regulatory Compliance

AI in clinical development; clinical trials; drug discovery; protocol design; patient recruitment; data analysis; regulatory compliance

Roche injects $550M into Indianapolis hub to scale up CGM production

2 months ago talkbio0Tagged Continuous glucose monitoring, Indianapolis, Investments, Manufacture, production, Roche (company), United States

Indianapolis, Roche (company), Continuous glucose monitoring, production, Manufacture, Investments, United States

Chronic care startup Omada Health files to go public

2 months ago talkbio0Tagged Administration occupational activities, cardiometabolic, Chronic Care Management, Diabetes, digital health, Health, Hinge Health, Hypertensive disease, IPO, musculoskeletal conditions, revenue growth, virtual care

Chronic care management, virtual care, IPO, digital health, diabetes management, cardiometabolic health, hypertension, musculoskeletal conditions, revenue growth, Hinge Health

Roche could rethink $50B US expansion plan if new policies ‘harm’ operations

2 months ago talkbio0Tagged expansion, Infantile Neuroaxonal Dystrophy, Investments, Policy, Roche (company), United States

Roche (company), United States, Investments, expansion, Policy, Infantile Neuroaxonal Dystrophy

Accelerating Clinical Trial Excellence: A Seamless IRB & IBC Collaboration

2 months ago talkbio0Tagged Biosafety, Clinical Trials, Collaboration, Efficiency, Ethics Committees, Research, Homo sapiens, IBC, multi-institutional research, regulatory, research, streamlined review

Clinical trials, IRB, IBC, collaboration, streamlined review, multi-institutional research, regulatory efficiency, research acceleration, biosafety, human subject protection

Pivotal readouts on deck as Takeda sees stagnant sales this year

3 months ago talkbio0Tagged Growth, JPY, Phase 3, Pivotal, Sales - occupational activity, Takeda

Takeda, Phase 3, Pivotal, Growth, Sales – occupational activity, JPY

AI Drug Discovery Firm Insitro Lays Off 22% of Workforce Amid Ongoing Biotech Market Turmoil

3 months ago talkbio0Tagged Ambulatory Care Facilities, Aortic Valve Insufficiency, Artificial Intelligence, Biotech Layoffs, biotechnology layoffs, Drug Discovery, Industry, Insitro, Market, Readiness, restructuring, trends qualifier

Insitro, AI drug discovery, biotechnology layoffs, workforce reduction, tumultuous market, industry restructuring, biotech market trends, clinic readiness, cost-cutting, 2025 biotech layoffs